AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Photocure ASA

Report Publication Announcement Apr 6, 2022

3714_10-k_2022-04-06_24d885af-f3a1-4aeb-9949-b78f5d482083.html

Report Publication Announcement

Open in Viewer

Opens in native device viewer

Photocure ASA: Annual Report 2021

Photocure ASA: Annual Report 2021

Oslo, Norway, 6 April 2022: Photocure ASA today announces the publication of the

Annual Report 2021, included the ESG report for 2021.

The Board of Directors of Photocure ASA has approved the annual accounts for

2021. The financial statements and annual report for the financial year 2021 are

together with the ESG report and auditor's report attached to this notice. The

ESEF file for 2021 is also attached.

The documents are enclosed and also made available at the company's website

under https://photocure.com/investors-hub/investors-events-and

-presentations (https://photocure.com/investor/reports-and-presentations/).

For further information, please contact:

Photocure

CFO Erik Dahl

Tel: +47 450 55 000

Email: [email protected]

About Photocure ASA:

Photocure: The Bladder Cancer Company delivers transformative solutions to

improve the lives of bladder cancer patients. Our unique technology, making

cancer cells glow bright pink, has led to better health outcomes for patients

worldwide. Photocure is headquartered in Oslo, Norway, and listed on the Oslo

Stock Exchange (OSE: PHO). For more information, please visit us at

www.photocure.com, www.hexvix.com or www.cysview.com. All trademarks mentioned

in this release are protected by law and are registered trademarks of Photocure

ASA. This information is subject to the disclosure requirements pursuant to

sections 5-12 of the Norwegian Securities Trading Act.

Talk to a Data Expert

Have a question? We'll get back to you promptly.